A 52-year-old man with a 30-year history of smoking undergoes endoscopy for chronic reflux symptoms. Biopsy of the distal esophagus shows columnar epithelium with intestinal-type mucosa (Barrett's esophagus). Which statement best distinguishes this finding from dysplasia?

Explanation

## Barrett's Esophagus: Metaplasia vs. Dysplasia ### Key Distinction **Key Point:** Barrett's esophagus is **metaplasia** — a reversible adaptive response to chronic acid reflux. However, it is a **pre-malignant condition** that carries increased risk of dysplasia and adenocarcinoma if the stimulus persists. ### Comparative Features | Feature | Metaplasia (Barrett's) | Dysplasia | |---------|------------------------|----------| | **Reversibility** | Reversible if reflux controlled | Irreversible | | **Cellular differentiation** | Preserved (columnar, mucus-secreting) | Lost (increased N:C ratio, hyperchromatic nuclei) | | **Architecture** | Normal glandular organization | Disarray, crowded glands, loss of maturation | | **Mitotic activity** | Normal | Increased, including abnormal mitoses | | **Genetic changes** | Epigenetic, no mutations | Accumulation of mutations (p53, APC, etc.) | | **Cancer risk** | Increased (0.1–0.3% per year) | High (30–50% progress to cancer) | | **Response to stimulus removal** | May regress | Will not regress | ### Pathogenesis of Barrett's Esophagus ```mermaid flowchart TD A[Chronic GERD]:::action --> B[Repeated acid injury to squamous epithelium]:::outcome B --> C[Stem cell reprogramming]:::action C --> D[Metaplasia: Columnar epithelium replaces squamous]:::outcome D --> E{Reflux continues?}:::decision E -->|Yes| F[Chronic inflammation, oxidative stress]:::action F --> G[Accumulation of genetic mutations]:::action G --> H[Dysplasia develops]:::urgent E -->|No| I[Metaplasia may regress]:::outcome ``` **High-Yield:** Barrett's esophagus itself is **NOT dysplasia** — it is metaplasia with increased cancer risk. Dysplasia is diagnosed only when histologic features of loss of differentiation and architectural disarray appear. **Clinical Pearl:** Surveillance endoscopy with 4-quadrant biopsies every 2–3 years is recommended for Barrett's without dysplasia; dysplasia (especially high-grade) warrants endoscopic therapy (radiofrequency ablation, endoscopic mucosal resection). **Mnemonic:** **MARC vs. DARN** — Metaplasia is Adaptive, Reversible, and maintains Cellular organization; Dysplasia shows Disarray, Atypia, Reversibility lost, and Neoplastic potential.